Liz Garrett-Mayer, PhD
@LGM_Biostats
Followers
539
Following
5K
Media
52
Statuses
609
Oncology Biostatistician @ ASCO's CENTRA. Bowdoin grad | Hopkins grad | Jersey girl. Rescue is the best breed. Tweets are my own.
Alexandria, VA
Joined December 2017
What a great discussion! Enjoyed learning new perspectives on Pragmatic Trials from FDA expert @DrDonnaRivera, @JhanelleGray from Moffitt and @ShaalanBeg from NCI. I shared lessons learned from @ASCO 's 2 pragmatic trials (TAPUR & CDK Study). Thanks for inviting me, @FDAOncology.
1
1
7
Cancer research and biostats friends, @ASCO's CENTRA is hiring a new division director! We are looking for a highly collaborative & motivated clinical researcher with MD or PhD, ideally with experience in cancer clinical trials. https://t.co/H8zDRrzLct
linkedin.com
Today’s top 55,000+ Records Management Specialist jobs in United States. Leverage your professional network, and get hired. New Records Management Specialist jobs added daily.
0
0
0
@ASCO & @CancerResrch recently submitted our public comments in response to @US_FDA's latest draft guidance documents that focus on performance status, laboratory values & criteria on washout periods & concomitant medications. View our comments here: https://t.co/R2tACPMkOl
1
1
2
We had some great discussions about strategies to increase and diversify trial enrollment. Let’s keep the conversation and momentum going! #ClinicalTrialsForum
Thrilled to join #ClinicalTrialsForum on ways to improve access to clinical trials & foster equity. ASCO recently shared steps for oncology research/clinical care communities to expand access to trials & help patients to participate closer to home. More:
0
0
13
Loved learning @ASCOPres ‘s career journey at @asco. Inspired by her work and impressed by her adventures!
Thank you @ASCO leadership & staff for inviting me to share my presidential theme & fun facts about myself, as well as the 2 decades-long perspective of a community doc serving rural communities. Such a fun day at HQ—I’m so excited for the year ahead!
0
3
9
Excited to participate in the @WHOSTP #ClinicalTrialsForum today representing @ASCO and sharing our efforts to increase access to clinical trials for patients with cancer.
This Wednesday, June 26, at 10AM ET, @WHOSTP is hosting the White House #ClinicalTrialsForum to build pathways to increase access, lower barriers to participation, and speed discovery of effective therapies. You can tune in at: https://t.co/322kKNAI40
1
0
5
This biostatistician loves this slide from Dr. Lillian Siu, Karnosky Award winner at #ASCO2024. Let’s make her clinical trials design future a reality.
0
0
9
Powerful words from Dr. Abraham Verghese at #ASCO24 : There is a difference between curing and healing.
0
1
2
Just released: The American Cancer Society and the American Society of Clinical Oncology are collaborating to create one of the largest online resources for people with cancer and their families. #ASCO24
https://t.co/1uDi5LUEL4
0
2
4
@UChiPritzker @fredhow @ASCO @LGM_Biostats @OpenAI @jcocci_asco will publish @fredhow @LGM_Biostats work "Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts from 2021 to 2023" and #JCOCCI EIC Dr. Jeremy Warner to discuss live. 📍June 2, 10:00AM S403B. (Journals Lounge) (4/n)
1
5
8
Share your voice to @FDAOncology's Project 5 in 5 crowdsourcing initiative - seeking ideas to identify 5 clinically relevant questions using FDA-approved oncology therapies that can be answered through pragmatic clinical trials over the next 5 years.
1
8
20
Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsies - Laura A Levit, Elizabeth Garrett-Mayer, Jeffrey Peppercorn, Mark J Ratain. @SCTorg #clinicaltrials #trialdesign #researchethics
journals.sagepub.com
This article reviews the implementation challenges to the American Society of Clinical Oncology’s ethical framework for including research biopsies in oncology ...
0
1
2
Julia Maues and other patient advocates from the Patient-Centered Dosing Initiative weigh in on their views on patient-centered dosing in this article in a series that addresses dose optimization in early phase cancer trials. @the_rightdose @itsnot_pink @SCTorg @LGM_biostats #FDA
0
3
5
Excellent article in Clinical Trials Special Issue on Dose Optimization. Thank you @CChiuzan and @HakDehbi for your contribution! @SCTorg
New article published on my birthday. What are the chances?! @HakDehbi The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies - Cody Chiuzan, Hakim-Moulay Dehbi, 2024
1
0
1
Looking forward to this! Please join us on May 6!
Join us for a virtual Grand Rounds on 5/6 to learn the latest from the #TAPUR Study, an ongoing clinical trial investigating targeted therapies for advanced cancer. Speakers include: @rschilsky @JFreemanDaily & Dr. Jens Rueter. Register: https://t.co/p7xTXIQaR7
#PrecisionMedicine
0
3
9
Recently published online (early access) in Clinical Trials. Grateful to co-editors of Special Issue on Dose Optimization, especially Peter Thall, whose good humor & wit made the work more enjoyable. Stay tuned for full issue! #doseoptimization @SCTorg
https://t.co/7Rdd2EJ88U
0
1
7
Michael Lotze named editor-in-chief of SITC’s (@sitcancer) 𝐽𝑜𝑢𝑟𝑛𝑎𝑙 𝑓𝑜𝑟 𝐼𝑚𝑚𝑢𝑛𝑜𝑇ℎ𝑒𝑟𝑎𝑝𝑦 𝑜𝑓 𝐶𝑎𝑛𝑐𝑒𝑟 (@jitcancer). https://t.co/rTmvuSKXb5
0
5
15